PlanDefinitions (111)

NameSourceVerDescription
Allgemeine und neurologische Anamnesefhir.qpath4ms#currentR4PlanDefinition zur allgemeinen und neurologischen Anamnese
Allgemeine und neurologische Untersuchungfhir.qpath4ms#currentR4PlanDefinition zur allgemeinen und neurologischen Untersuchung
ANC.B Routine contactwho.fhir.anc-cds#currentR4To counsel and provide ANC services to a pregnant woman
ANC.DT.01 Danger signswho.fhir.anc-cds#currentR4Before each contact, during the Quick Check, the health worker should check whether the woman has any of the danger signs listed here – if yes, she should be referred to the hospital urgently; if no, the normal contact should be continued as normal
ANC.DT.01 Danger signsexample.fhir.uv.mycontentig#currentR4Before each contact, during the Quick Check, the health worker should check whether the woman has any of the danger signs listed here – if yes, she should be referred to the hospital urgently; if no, the normal contact should be continued as normal
ANC.DT.02 Adolescent HEADSS asessementwho.fhir.anc-cds#currentR4If client is an adolescent, conduct Home-Eating-Activity-Drugs-Sexuality-Safety-Suicide (HEADSS) assessment
ANC.DT.03 Check symptoms and follow upwho.fhir.anc-cds#currentR4Depending on current and/or persistant symptoms, physiological symptoms counselling may be required
ANC.DT.04 Conducting physical examswho.fhir.anc-cds#currentR4Depending on the results of some physical exams, additional examinations or repeat measurements are required
ANC.DT.05 Evaluating labourwho.fhir.anc-cds#currentR4During a cervical exam, if cervical dilation is greater than 2 cm evaluate the possibility of labour
ANC.DT.06 Physical symptoms and exam results requiring referralwho.fhir.anc-cds#currentR4If the woman has any of the following physical exam results, refer to the hospital
ANC.DT.07 Ultrasound recommendationwho.fhir.anc-cds#currentR4An ultrasound is recommended for all pregnant women before 24 weeks of gestation (early ultrasound). If there's no ultrasound available at that health-carte facility, the woman should be referred to another facility in which she can receive an ultrasound.
ANC.DT.08 HIV testingwho.fhir.anc-cds#currentR4Depending on the population prevalence, and woman's medical history, conduct HIV testing
ANC.DT.09 Heptatitis B testingwho.fhir.anc-cds#currentR4Depending on the population prevalence, and woman's medical history, conduct hepatitis B testing
ANC.DT.10 Hepatitis C testingwho.fhir.anc-cds#currentR4Depending on the population prevalence, and woman's medical history, conduct hepatitis C testing
ANC.DT.11 Syphilis testingwho.fhir.anc-cds#currentR4Depending on the contact schedule, and woman's syphilis diagnosis, test for syphilis
ANC.DT.12 Urine testingwho.fhir.anc-cds#currentR4Conditions in which urine testing is required
ANC.DT.13 Tuberculosis screeningwho.fhir.anc-cds#currentR4Conditions in which screening for TB is recommended
ANC.DT.14 Otherwho.fhir.anc-cds#currentR4Additional blood tests
ANC.DT.15 Behaviour counselling requiredwho.fhir.anc-cds#currentR4Depending on the woman's behaviours reported during the first contact and the woman's reported persistent behaviours, additional counselling may or may not be required
ANC.DT.16 Dietary counsellingwho.fhir.anc-cds#currentR4ALL women should have "Healthy eating and keeping physically active counselling" with guidance on nutrition and exercise. If a woman is classified as "underweight" AND she is part of a population whereby the prevalence of undernourishment is greater than or equal to 20%, then additional dietary counselling is needed.
ANC.DT.17 Pre-eclampsia, severe pre-eclampsia and hypertension diagnosiswho.fhir.anc-cds#currentR4If the woman presents with any of the following symptoms and/or test results, conduct counselling and referral as needed
ANC.DT.18 HIV diagnosiswho.fhir.anc-cds#currentR4If the woman tests positive for HIV, provide counselling and referral as needed
ANC.DT.19 Hepatitis B diagnosiswho.fhir.anc-cds#currentR4If the woman tests positive for hepatitis B, provide counselling and referral as needed
ANC.DT.20 Hepatitis C diagnosiswho.fhir.anc-cds#currentR4If the woman tests positive for hepatitis C, provide counselling and referral as needed
ANC.DT.21 Syphilis diagnosiswho.fhir.anc-cds#currentR4If the woman tests positive for syphilis, provide counselling and treatment as needed
ANC.DT.22 Asymptomatic bacteriuria (ASB) diagnosiswho.fhir.anc-cds#currentR4If the woman tests positive for ASB, provide counselling and treatment as needed.
ANC.DT.23 Gestational diabetes mellitus (GDM) and diabetes mellitus (DM) during pregnancy diagnosiswho.fhir.anc-cds#currentR4If the woman's blood glucose test results are as follows, provide the necessary counselling and treatment
ANC.DT.24 TB diagnosiswho.fhir.anc-cds#currentR4If the woman's TB screening results are positive for TB, provide the required treatment as per local TB protocols
ANC.DT.25 Anaemia, iron and folic acid supplementationwho.fhir.anc-cds#currentR4Testing for anaemia is recommended for all pregnant women. Regardless of test results, iron and folic acid supplementation is recommended. The amount of iron and folic acid supplementation will vary depending on anaemia diagnosis, population prevalence of anaemia, and whether the woman has side-effects due to iron and folic acid supplementation.
ANC.DT.26 Calcium and vitamin A supplementationwho.fhir.anc-cds#currentR4Depending on the population, additional calcium and/or vitamin A supplements maybe required
ANC.DT.27 Pre-eclampsia risk counsellingwho.fhir.anc-cds#currentR4If the woman has risk factors for developing pre-eclampsia, provide counselling to reduce risk of developing pre-eclampsia
ANC.DT.28 Gestational diabetes mellitus (GDM) risk counsellingwho.fhir.anc-cds#currentR4If the woman has risk factors for developing gestational diabetes mellitus (GDM), provide counselling to reduce risk of developing GDM
ANC.DT.29 HIV risk counsellingwho.fhir.anc-cds#currentR4If the woman has risk factors for contracting HIV, provide counselling to reduce risk of contracting HIV
ANC.DT.30 General risk reduction counsellingwho.fhir.anc-cds#currentR4Depending on a variety of risk factors and/or gestational age, provide additional counselling accordingly
ANC.DT.31 Flu immunizationwho.fhir.anc-cds#currentR4If the woman has not yet been immunized with the seasonal flu vaccine, she should be immunized
ANC.DT.32 Tetanus toxoid-containing vaccinationwho.fhir.anc-cds#currentR4If the woman has not yet been fully immunized against tetanus, she should be immunized
ANC.DT.33 Breastfeeding counsellingwho.fhir.anc-cds#currentR4General counselling to be provided/reviewed at every contact
ANC.DT.34 Birth preparedness counsellingwho.fhir.anc-cds#currentR4General counselling to be provided/reviewed at every contact
ANC.DT.35 Family planning counsellingwho.fhir.anc-cds#currentR4General counselling to be provided/reviewed at every contact
ANC.DT.36 Intimate partner violence (IPV) clinical inquirywho.fhir.anc-cds#currentR4You may suspect that a woman has been subjected to intimiate partner violence if she has any of the following risk factors
ANC.DT.37 Intimate partner violence (IPV) first-line support and treatmentwho.fhir.anc-cds#currentR4Woman has been subjected to IPV
ANC.DT.38 Deworming and malaria prophylaxiswho.fhir.anc-cds#currentR4IF the woman is currently in a malaria-endemic setting, or in an area where there is greater than 20% prevalence of infection with any soil-transmitted helminths, THEN she should receive preventative treatment accordingly
ANC.S.01 Contact schedulewho.fhir.anc-cds#currentR4To counsel and provide ANC services to a pregnant woman
Arztvorstellungfhir.qpath4ms#currentR4PlanDefinition zur Arztvorstellung
Auswertungfhir.qpath4ms#currentR4PlanDefinition zur Auswertung
Basismonitoring - Besuch M3 / M9fhir.qpath4ms#currentR4PlanDefinition zum Basismonitoring-Patientepfad zum Besuchstermin im 3./9. Monat
Basismonitoring - Besuch M6fhir.qpath4ms#currentR4PlanDefinition zum Basismonitoring-Patientepfad zum Besuchstermin im 6. Monat
Basismonitoring - M0fhir.qpath4ms#currentR4PlanDefinition zum Basismonitoring-Patientepfad zum Besuchstermin im 0. Monat
Basismonitoring Patientenpfad - 1 Jahreszyklusfhir.qpath4ms#currentR4PlanDefinition zum Basismonitoring-Patientenpfad für einen Jahreszyklus
Befundauswertungfhir.qpath4ms#currentR4PlanDefinition zur Befundauswertung
BgZ 2017hl7.fhir.nl.zorgviewer#currentR3
Check-Infhir.qpath4ms#currentR4PlanDefinition zum Check-In
Check-Outfhir.qpath4ms#currentR4PlanDefinition zum Check-Out
Colorectal Cancer Screening CDSfhir.cqf.ccc#currentR4
Ganganalysefhir.qpath4ms#currentR4PlanDefinition zur Ganganalyse
Hello HIV Worldfhir.nachc.hiv-cds#currentR4This PlanDefinition defines a simple recommendation handling the sampling of HIV
High Blood Pressure Warninghl7.fhir.us.ohsuhypertensionig#currentR4This PlanDefinition detects a recent high blood pressure reading.
Hypertension Diagnosishl7.fhir.us.ohsuhypertensionig#currentR4This PlanDefinition looks for indications a patient should be diagnosed with hypertension.
IMMZ.DT.01.BCGwho.fhir.immunization#currentR4If child or person has not been vaccinated, give BCG vaccine as soon as possible after birth
IMMZ.DT.02.HepatitisBwho.fhir.immunization#currentR4If child or person has not been vaccinated, give Hepatitis B vaccine as soon as possible after birth
IMMZ.DT.03.Poliowho.fhir.immunization#currentR4If child or person has not been vaccinated, give Polio vaccine
IMMZ.DT.04.DTPwho.fhir.immunization#currentR4If child or person has not been given DTP, start scheme
IMMZ.DT.05.Hibwho.fhir.immunization#currentR4if child or person has not been vaccinated, give Hib vaccine between 6 weeks and 59 months
IMMZ.DT.06.Pneumococcalwho.fhir.immunization#currentR4If child or person has not been vaccinated, give Pneumococcal vaccine minimum age 6 weeks old
IMMZ.DT.07.Rotaviruswho.fhir.immunization#currentR4If child or person has not been vaccinated, give Rotavirus vaccine according to the defined schedule
IMMZ.DT.08.Measleswho.fhir.immunization#currentR4If the child or patient has not been given MCV1 (at 9 months) and MCV2 (between 15-18 months) vaccination
IMMZ.DT.09.Rubellawho.fhir.immunization#currentR4If child or patient has not received the Rubella vaccination and is greater than or equal to 9 months
IMMZ.DT.10.HPVwho.fhir.immunization#currentR4If child or person has not been vaccinated, give HPV vaccine according to the defined schedule
IMMZ.DT.11.JapaneseEncephalitiswho.fhir.immunization#currentR4If child or person has not been vaccinated, give Japanese Encephalitis vaccine according to the defined schedule
IMMZ.DT.12.YellowFeverwho.fhir.immunization#currentR4If child or person has not been vaccinated, give Yellow Fever vaccine between age 9-12 months
IMMZ.DT.13.Tick-BorneEncephalitiswho.fhir.immunization#currentR4If child or person has not been vaccinated, give Tick-Borne Encephalitis vaccine according to the defined schedule
IMMZ.DT.14.Typhoidwho.fhir.immunization#currentR4If child or person has not been vaccinated, give the Typhoid vaccine between age 6 months - 45 years old
IMMZ.DT.15.Cholerawho.fhir.immunization#currentR4If child or person has not been vaccinated, give the Cholera vaccine to child greater than or equal to 1 year old and adults
IMMZ.DT.16.Meningococcalwho.fhir.immunization#currentR4If child or person has not been vaccinated, give Meningococcal vaccine according to the defined schedule
IMMZ.DT.17.HepatitisAwho.fhir.immunization#currentR4If child or person has not been vaccinated, give Hepatitis A vaccine at 1 year of age
IMMZ.DT.18.Rabieswho.fhir.immunization#currentR4If patient has not been vaccinated, give Rabies vaccine
IMMZ.DT.19.Denguewho.fhir.immunization#currentR4If child or person has not been vaccinated, give Dengue vaccine between 9 and 45 years of age
IMMZ.DT.20.Mumpswho.fhir.immunization#currentR4If child or person has not been vaccinated against Mumps, give Mumps vaccine
IMMZ.DT.21.SeasonalInfluenzawho.fhir.immunization#currentR4If child or person has not been vaccinated, give Seasonal Influenza vaccine at 6 months of age, and then once a year.
IMMZ.DT.22.Varicellawho.fhir.immunization#currentR4If child or person has not been vaccinated against Varicella
Laboruntersuchungfhir.qpath4ms#currentR4PlanDefinition zur Laboruntersuchung
Magnetresonanztomographiefhir.qpath4ms#currentR4PlanDefinition zur Magnetresonanztomographie (MRT)
Monitoringhl7.fhir.us.ohsuhypertensionig#currentR4This PlanDefinition provides patient recommendations for monitoring a preexisting Hypertension condition.
Multiple Sclerosis Performance Testfhir.qpath4ms#currentR4PlanDefinition zum Multiple Sclerosis Performance Test (MSPT)
NACHC HIV Screeningfhir.nachc.hiv-cds#currentR4This PlanDefinition defines a Clinical Decision Support rule to determine whether HIV Screening is appropriate based on CDC Recommendations for HIV Screening
Optische Kohärenztomographiefhir.qpath4ms#currentR4PlanDefinition zur Optischen Kohärenztomographie (OCT)
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #1fhir.cdc.opioid-cds-r4#currentR4Nonpharmacologic therapy and nonopioid pharmacologic therapy are preferred for subacute or chronic pain.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10fhir.cdc.opioid-cds-r4#currentR4When prescribing opioids for subacute or chronic pain, providers should use urine drug testing before starting opioid therapy and consider urine drug testing at least annually to assess for prescribed medications as well as other controlled prescription drugs and illicit drugs.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 (order-sign)fhir.cdc.opioid-cds-r4#currentR4When prescribing opioids for subacute or chronic pain, providers should use urine drug testing before starting opioid therapy and consider urine drug testing at least annually to assess for prescribed medications as well as other controlled prescription drugs and illicit drugs.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #10 (patient-view)fhir.cdc.opioid-cds-r4#currentR4When prescribing opioids for subacute or chronic pain, providers should use urine drug testing before starting opioid therapy and consider urine drug testing at least annually to assess for prescribed medications as well as other controlled prescription drugs and illicit drugs.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #11fhir.cdc.opioid-cds-r4#currentR4Concurrently prescribing opioid medications with benzodiazepines increases the risk of harm for the patient.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #11 (patient-view)fhir.cdc.opioid-cds-r4#currentR4Concurrently prescribing opioid medications with benzodiazepines increases the risk of harm for the patient.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #12 (patient-view)fhir.cdc.opioid-cds-r4#currentR4Arrange evidence-based treatment (usually medication-assisted treatment with buprenorphine or methadone in combination with behavioral therapies) for patients with opioid use disorder.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #2fhir.cdc.opioid-cds-r4#currentR4Nonpharmacologic therapy and nonopioid pharmacologic therapy are preferred for chronic pain.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #3fhir.cdc.opioid-cds-r4#currentR4When starting opioid therapy for subacute or chronic pain, clinicians should prescribe immediate-release opioids instead of extended-release/long-acting (ER/LA) opioids.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #6fhir.cdc.opioid-cds-r4#currentR4When opioids are used for acute pain, clinicians should prescribe the lowest effective dose of immediate-release opioids and should prescribe no greater quantity than needed for the expected duration of pain severe enough to require opioids.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #7fhir.cdc.opioid-cds-r4#currentR4Clinicians should evaluate benefits and harms with patients within 1 to 4 weeks of starting opioid therapy for subacute or chronic pain or of dose escalation. Clinicians should evaluate benefits and harms of continued therapy with patients every 3 months or more frequently.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #8fhir.cdc.opioid-cds-r4#currentR4Clinicians should incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose, such as history of overdose, history of substance use disorder, higher opioid dosages (≥50 MME/day), or concurrent benzodiazepine use, are present.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #8 (order-sign)fhir.cdc.opioid-cds-r4#currentR4Clinicians should incorporate into the management plan strategies to mitigate risk, including considering offering naloxone when factors that increase risk for opioid overdose, such as history of overdose, history of substance use disorder, higher opioid dosages (≥50 MME/day), or concurrent benzodiazepine use, are present.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendation #9fhir.cdc.opioid-cds-r4#currentR4Clinicians should review PDMP data when starting opioid therapy for subacute or chronic pain and periodically during opioid therapy for chronic pain.
PlanDefinition - 2022 CDC Clinical Practice Guideline for Prescribing Opioids for Pain: Recommendations #4 and #5fhir.cdc.opioid-cds-r4#currentR4When opioids are started, providers should prescribe the lowest effective dosage.
Potential Adverse Reaction Detectionhl7.fhir.us.ohsuhypertensionig#currentR4This PlanDefinition detects recent adverse reactions that could be related to Hypertension medication.
Template for COVID-19 Care in the Community CCCM MVP Careplanscinc.fhir.ig#currentR4Creates a care plan suitable for a low to medium-risk COVID-19 case: patient activities include medication delivery, heath checks, RAT self-test and follow-up GP Check
Terminvereinbarungfhir.qpath4ms#currentR4PlanDefinition zur Terminvereinbarung
Therapiespezifische Diagnostikfhir.qpath4ms#currentR4PlanDefinition zur therapiespezifischen Diagnostik
Therapy - Medicineshl7.fhir.us.ohsuhypertensionig#currentR4This PlanDefinition provides pharmacologic recommendations for patients with Hypertension
Therapy - Non-medicinalhl7.fhir.us.ohsuhypertensionig#currentR4This PlanDefinition identifies Non-Pharmacologic Interventions for Hypertension
Voruntersuchungenfhir.qpath4ms#currentR4PlanDefinition zu Voruntersuchungen
Voruntersuchungenfhir.qpath4ms#currentR4PlanDefinition zu Voruntersuchungen (M3 + M9)
Voruntersuchungenfhir.qpath4ms#currentR4PlanDefinition zu Voruntersuchungen (M6)
Zusatzdiagnostikfhir.qpath4ms#currentR4PlanDefinition zur Zusatzdiagnostik

Produced 08 Sep 2023